Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 621 shares at $277.95 ($173K) on 2022-07-29, disclosed to the SEC on 2022-08-02.
Open-market sale of $173k VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $276.65 | 99 | $27K | 15.8% |
| 2 | $277.95 | 200 | $56K | 32.1% |
| 3 | $279.28 | 160 | $45K | 25.8% |
| 4 | $280.22 | 99 | $28K | 16.0% |
| 5 | $281.03 | 58 | $16K | 9.4% |
| 6 | $282.34 | 5 |
| $1K |
| 0.8% |
| Total | $278.77 avg | 621 | $173K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |